PGC-1α activation as a therapeutic approach in mitochondrial disease

IUBMB Life

Volumn 61, Issue 11, 2009, Pages 1051-1062

  Wenz, Tina ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Mitochondria; Mitochondrial biogenesis; Mitochondrial disease; PGC 1

Indexed keywords

ADENOSINE TRIPHOSPHATE; MITOCHONDRIAL DNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1; PEROXISOME-PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA COACTIVATOR-1; TRANSCRIPTION FACTOR;

BIOGENESIS; BIOSYNTHESIS; CELL VIABILITY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA REPLICATION; DNA TRANSCRIPTION; ELECTRON; ENZYME ACTIVATION; HUMAN; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PROTEIN ASSEMBLY; QUALITY CONTROL; REVIEW; ANIMAL; GENETICS; MITOCHONDRION; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALIA;

ANIMALS; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DNA, MITOCHONDRIAL; HUMANS; MITOCHONDRIA; MITOCHONDRIAL DISEASES; OXIDATIVE PHOSPHORYLATION; TRANSCRIPTION FACTORS;

EID: 77449139468     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.261     Document Type: Review

References (141)

1. Saraste, M. (1999) Oxidative phosphorylation at the fin de siecle. Science 283, 1488-1493.
2. DiMauro, S. and Schon, E. A. (2008) Mitochondrial disorders in the nervous system. Annu. Rev. Neurosci. 31, 91-123.
3. Schaefer, A. M., McFarland, R., Blakely, E. L., He, L., Whittaker, R. G., Taylor, R.W., Chinnery, P. F., and Turnbull, D. M. (2008) Prevalence of mitochondrial DNA disease in adults. Ann. Neurol. 63, 35-39.
4. Dimauro, S. and Rustin, P. (2008) A critical approach to the therapy of mitochondrial respiratory chain and oxidative phosphorylation diseases. Biochim. Biophys. Acta. doi:10.1016/j.bbadis.2008.10.015.
5. Koene, S. and Smeitink, J. (2009) Mitochondrial medicine: entering the era of treatment. J. Intern. Med. 265, 193-209.
6. Horvath, R., Gorman, G., and Chinnery, P. F. (2008) How can we treat mitochondrial encephalomyopathies? Approaches to therapy. Neurotherapeutics 5, 558-568.
7. Srivastava, S., Diaz, F., Iommarini, L., Aure, K., Lombes, A., and Moraes, C. T. (2009) PGC-1a/b induced expression partially compensates for respiratory chain defects in cells from patients with mitochondrial disorders. Hum. Mol. Genet. 18, 1805-1812.
8. Wenz, T., Diaz, F., Spiegelman, B. M., and Moraes, C. T. (2008) Activation of the PPAR/PGC-1a pathway prevents a bioenergetic deficit and effectively improves a mitochondrial myopathy phenotype. Cell. Metab. 8, 249-256.
9. Wenz, T., Diaz, F., Hernandez, D., and Moraes, C. T. (2009) Endurance exercise is protective for mice with mitochondrial myopathy. J. Appl. Physiol. 106, 1712-1719.
10. Bastin, J., Aubey, F., Rotig, A., Munnich, A., and Djouadi, F. (2008) Activation of peroxisome proliferator-activated receptor pathway stimulates the mitochondrial respiratory chain and can correct deficiencies in patients' cells lacking its components. J. Clin. Endocrinol. Metab. 93, 1433-1441.
11. Murphy, M. P. (2009) How mitochondria produce reactive oxygen species. Biochem. J. 417, 1-13.
12. Melov, S. (2002) Therapeutics against mitochondrial oxidative stress in animal models of aging. Ann. N. Y. Acad. Sci. 959, 330-340.
13. de Vries, H. E., Witte, M., Hondius, D., Rozemuller, A. J., Drukarch, B., Hoozemans, J., and van Horssen, J. (2008) Nrf2-induced antioxidant protection: a promising target to counteract ROS-mediated damage in neurodegenerative disease? Free. Radic. Biol. Med. 45, 1375-1383.
14. Beal, M. F. (2005) Mitochondria take center stage in aging and neurodegeneration. Ann. Neurol. 58, 495-505.
15. Beal, M. F. (2002) Oxidatively modified proteins in aging and disease. Free. Radic. Biol. Med. 32, 797-803.
16. Ristow, M., Zarse, K., Oberbach, A., Kloting, N., Birringer, M., Kiehntopf, M., Stumvoll, M., Kahn, C. R., and Bluher, M. (2009) Antioxidants prevent health-promoting effects of physical exercise in humans. Proc. Natl. Acad. Sci. USA 106, 8665-8670.
17. Anderson, S., Bankier, A. T., Barrell, B.G., de Bruijn, J., Coulson, A. R., Drouin, J., Eperon, I. C., Nierlich, D. P., Roe, B. A., Sanger, F., Schreier, P. H., Smith, A. J., Staden, R., and Young, I. G. (1981) Sequence and organization of the human mitochondrial genome. Nature 290, 457-465.
18. Scarpulla, R. C. (2008) Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiol. Rev. 88, 611-638.
19. Spelbrink, J. N., Li, F. Y., Tiranti, V., Nikali, K., Yuan, Q. P., Tariq, M., Wanrooij, S., Garrido, N., Comi, G., Morandi, L., Santoro, L., Toscano, A., Fabrizi, G. M., Somer, H., Croxen, R., Beeson, D., Poulton, J., Suomalainen, A., Jacobs, H. T., Zeviani, M., and Larsson, C. (2001) Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria. Nat. Genet. 28, 223-231.
20. Muller-Hocker, J., Schafer, S., and Li, K. (2001) Immunocytochemical localization of mitochondrial single-stranded DNA-binding protein in mitochondria-rich cells of normal and neoplastic human tissue. Appl. Immunohistochem. Mol. Morphol. 9, 276-280.
21. Graziewicz, M. A., Longley, M. J., and Copeland, W. C. (2006) DNA polymerase gamma in mitochondrial DNA replication and repair. Chem. Rev. 106, 383-405.
22. Roberti, M., Polosa, P. L., Bruni, F., Manzari, C., Deceglie, S., Gadaleta, M. N., and Cantatore, P. (2009) The MTERF family proteins: mitochondrial transcription regulators and beyond. Biochim. Biophys. Acta. 1787, 303-311.
23. Park, C. B., Asin-Cayuela, J., Camara, Y., Shi, Y., Pellegrini, M., Gaspari, M., Wibom, R., Hultenby, K., Erdjument-Bromage, H., Tempst, P., Falkenberg, M., Gustafsson, C. M., and Larsson, N. G. (2007) MTERF3 is a negative regulator of mammalian mtDNA transcription. Cell 130, 273-285.
24. Wenz, T., Luca, C., Torraco, A., and Moraes, C. T. (2009) mTERF2 regulates oxidative phosphorylation by modulating mtDNA transcription. Cell. Metab. 9, 499-511.
25. Jacobs, H.T., and Turnbull, D. M. (2005) Nuclear genes and mitochondrial translation: a new class of genetic disease. Trends Genet. 21, 312-314.
26. Rugarli, E. I. and Langer, T. (2006) Translating m-AAA protease function in mitochondria to hereditary spastic paraplegia. Trends Mol. Med. 12, 262-269.
27. Nolden, M., Ehses, S., Koppen, M., Bernacchia, A., Rugarli, E. I., and Langer, T. (2005) The m-AAA protease defective in hereditary spastic paraplegia controls ribosome assembly in mitochondria. Cell. 123, 277-289.
28. Wiedemann, N., Frazier, A. E., and Pfanner, N. (2004) The protein import machinery of mitochondria. J. Biol. Chem. 279, 14473-14476.
29. Matouschek, A., Pfanner, N., and Voos, W. (2000) Protein unfolding by mitochondria. The Hsp70 import motor. EMBO Rep. 1, 404-410.
30. Hood, D. A., Adhihetty, P. J., Colavecchia, M., Gordon, J. W., Irrcher, I., Joseph, A. M., Lowe, S. T., and Rungi, A. A. (2003) Mitochondrial biogenesis and the role of the protein import pathway. Med. Sci. Sports. Exerc. 35, 86-94.
31. Voos, W. and Rottgers, K. (2002) Molecular chaperones as essential mediators of mitochondrial biogenesis. Biochim. Biophys. Acta. 1592, 51-62.
32. Perez-Martinez, X., Funes, S., Camacho-Villasana, Y., Marjavaara, S., Tavares-Carreon, F., and Shingu-Vazquez, M. (2008) Protein synthesis and assembly in mitochondrial disorders. Curr. Top. Med. Chem. 8, 1335-1350.
33. Koppen, M. and Langer, T. (2007) Protein degradation within mitochondria: versatile activities of AAA proteases and other peptidases. Crit. Rev. Biochem. Mol. Biol. 42, 221-242.
34. Yen, W.L. and Klionsky, D. J. (2008) How to live long and prosper: autophagy, mitochondria, and aging. Physiology (Bethesda) 23, 248-262.
35. Bota, D. A. and Davies, K. J. (2002) Lon protease preferentially degrades oxidized mitochondrial aconitase by an ATP-stimulated mechanism. Nat. Cell. Biol. 4, 674-680.
36. Klionsky, D. J. and Emr, S. D. (2000) Autophagy as a regulated pathway of cellular degradation. Science 290, 1717-1721.
37. Lemasters, J. J. (2005) Selective mitochondrial autophagy, or mitophagy, as a targeted defense against oxidative stress, mitochondrial dysfunction, and aging. Rejuvenation Res. 8, 3-5.
38. Kim, I., Rodriguez-Enriquez, S., and Lemasters, J. J. (2007) Selective degradation of mitochondria by mitophagy. Arch. Biochem. Biophys. 462, 245-253.
39. Scherz-Shouval, R., Shvets, E., Fass, E., Shorer, H., Gil, L., and Elazar, Z. (2007) Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4. EMBO J 26, 1749-1760.
40. Wikstrom, J. D., Twig, G., and Shirihai, O. S. (2009) What can mitochondrial heterogeneity tell us about mitochondrial dynamics and autophagy? Int. J. Biochem. Cell. Biol. 41, 1914-1927.
41. Kanki, T., Wang, K., Cao, Y., Baba, M., and Klionsky, D. J. (2009) Atg32 is a mitochondrial protein that confers selectivity during mitophagy. Dev. Cell. 17, 98-109.
42. Okamoto, K., Kondo-Okamoto, N., and Ohsumi, Y. (2009) Mitochondria-anchored receptor Atg32 mediates degradation of mitochondria via selective autophagy. Dev. Cell. 17, 87-97.
43. Twig, G., Hyde, B., and Shirihai, O. S. (2008) Mitochondrial fusion, fission, and autophagy as a quality control axis: the bioenergetic view. Biochim. Biophys. Acta. 1777, 1092-1097.
44. Tatsuta, T. and Langer, T. (2008) Quality control of mitochondria: protection against neurodegeneration and ageing. EMBO J. 27, 306-314.
45. Scorrano, L. (2007) Multiple functions of mitochondria-shaping proteins. Novartis Found. Symp. 287, 47-55; discussion 55-149
46. Yoon, Y., Krueger, E. W., Oswald, B. J., and McNiven, M. A. (2003) The mitochondrial protein hFis1 regulates mitochondrial fission in mammalian cells through an interaction with the dynaminlike protein DLP1. Mol. Cell. Biol. 23, 5409-5420.
47. James, D. I., Parone, P. A., Mattenberger, Y., and Martinou, J. C. (2003) hFis1, a novel component of the mammalian mitochondrial fission machinery. J. Biol. Chem. 278, 36373-36379.
48. Santel, A. and Frank, S. (2008) Shaping mitochondria: the complex posttranslational regulation of the mitochondrial fission protein DRP1. IUBMB Life 60, 448-455.
49. Ishihara, N., Eura, Y., and Mihara, K. (2004) Mitofusin 1 and 2 play distinct roles in mitochondrial fusion reactions via GTPase activity. J. Cell. Sci. 117, 653-6546.
50. de Brito, O. M. and Scorrano, L. (2008) Mitofusin 2: a mitochondriashaping protein with signaling roles beyond fusion. Antioxid. Redox Signal. 10, 621-633.
51. Olichon, A., Guillou, E., Delettre, C., Landes, T., Arnaune-Pelloquin, L., Emorine, L.J., Mils, V., Daloyau, M., Hamel, C., Amati-Bonneau, P., Bonneau, D., Reynier, P., Lenaers, G., and Belenguer, P. (2006) Mitochondrial dynamics and disease, OPA1. Biochim. Biophys. Acta. 1763, 500-509.
52. Schreiber, S. N., Knutti, D., Brogli, K., Uhlmann, T., and Kralli, A. (2003) The transcriptional coactivator PGC-1 regulates the expression and activity of the orphan nuclear receptor estrogen-related receptor alpha (ERRalpha). J. Biol. Chem. 278, 9013-9018.
53. Wu, Z., Puigserver, P., Andersson, U., Zhang, C., Adelmant, G., Mootha, V., Troy, A., Cinti, S., Lowell, B., Scarpulla, R. C., and Spiegelman, B. M. (1999) Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98, 115-124.
54. Lin, J., Wu, H., Tarr, P. T., Zhang, C. Y., Wu, Z., Boss, O., Michael, L. F., Puigserver, P., Isotani, E., Olson, E. N., Lowell, B. B., Bassel-Duby, R., and Spiegelman, B. M. (2002) Transcriptional co-activator PGC-1a drives the formation of slow-twitch muscle fibres. Nature 418, 797-801.
55. Hondares, E., Pineda-Torra, I., Iglesias, R., Staels, B., Villarroya, F., and Giralt, M. (2007) PPARd, but not PPARa, activates PGC-1α gene transcription in muscle. Biochem. Biophys. Res. Commun. 354, 1021-1027.
56. Gervois, P., Torra, I. P., Fruchart, J. C., and Staels, B. (2000) Regulation of lipid and lipoprotein metabolism by PPAR activators. Clin. Chem. Lab. Med. 38, 3-11.
57. Nehlin, J.O., Mogensen, J. P., Petterson, I., Jeppesen, L., Fleckner, J., Wulff, E. M., and Sauerberg, P. (2006) Selective PPAR agonists for the treatment of type 2 diabetes. Ann. N. Y. Acad. Sci. 1067, 448-453.
58. Cheng, A.Y. and Leiter, L. A. (2008) PPAR-a: therapeutic role in diabetes-related cardiovascular disease. Diabetes Obes. Metab. 10, 691-698.
59. Gross, B. and Staels, B. (2007) PPAR agonists: multimodal drugs for the treatment of type-2 diabetes. Best Pract. Res. Clin. Endocrinol. Metab. 21, 687-710.
60. Staels, B. (2007) PPAR agonists and the metabolic syndrome. Therapie 62, 319-326.
61. Barish, G. D., Narkar, V. A., and Evans, R. M. (2006) PPAR delta: a dagger in the heart of the metabolic syndrome. J. Clin. Invest. 116, 590-597.
62. Akiyama, T. E., Meinke, P. T., and Berger, J. P. (2005) PPAR ligands: potential therapies for metabolic syndrome. Curr. Diab. Rep. 5, 45-52.
63. Benton, C. R., Holloway, G. P., Campbell, S. E., Yoshida, Y., Tandon, N. N., Glatz, J. F., Luiken, J. J., Spriet, L. L., and Bonen, A. (2008) Rosiglitazone increases fatty acid oxidation and fatty acid translocase (FAT/CD36) but not carnitine palmitoyltransferase I in rat muscle mitochondria. J. Physiol. 586, 1755-1766.
64. Wu, Z., Huang, X., Feng, Y., Handschin, C., Gullicksen, P. S., Bare, O., Labow, M., Spiegelman, B., and Stevenson, S. C. (2006) Transducer of regulated CREB-binding proteins (TORCs) induce PGC-1α transcription and mitochondrial biogenesis in muscle cells. Proc. Natl. Acad. Sci. USA 103, 14379-14384.
65. Handschin, C., Rhee, J., Lin, J., Tarr, P. T., and Spiegelman, B. M. (2003) An autoregulatory loop controls peroxisome proliferatoractivated receptor gamma coactivator 1α expression in muscle. Proc. Natl. Acad. Sci. USA 100, 7111-7116.
66. Arany, Z., Foo, S. Y., Ma, Y., Ruas, J. L., Bommi-Reddy, A., Girnun, G., Cooper, M., Laznik, D., Chinsomboon, J., Rangwala, S. M., Baek, K. H., Rosenzweig, A., and Spiegelman, B. M. (2008) HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1a. Nature 451, 1008-1012.
67. O'Hagan, K. A., Cocchiglia, S., Zhdanov, A. V., Tambuwala, M. M., Cummins, E. P., Monfared, M., Agbor, T. A., Garvey, J. F., Papkovsky, D. B., Taylor, C. T., and Allan, B. B. (2009) PGC-1a is coupled to HIF-1α- dependent gene expression by increasing mitochondrial oxygen consumption in skeletal muscle cells. Proc. Natl. Acad. Sci. USA 106, 2188-2193.
68. Irrcher, I., Ljubicic, V., and Hood, D. A. (2009) Interactions between ROS and AMP kinase activity in the regulation of PGC-1α transcription in skeletal muscle cells. Am. J. Physiol. Cell. Physiol. 296, C116-C123.
69. Silveira, L. R., Pilegaard, H., Kusuhara, K., Curi, R., and Hellsten, Y. (2006) The contraction induced increase in gene expression of peroxisome proliferator-activated receptor (PPAR)-γ coactivator 1α (PGC-1α), mitochondrial uncoupling protein 3 (UCP3) and hexokinase II (HKII) in primary rat skeletal muscle cells is dependent on reactive oxygen species. Biochim. Biophys. Acta. 1763, 969-976.
70. Borniquel, S., Valle, I., Cadenas, S., Lamas, S., and Monsalve, M. (2006) Nitric oxide regulates mitochondrial oxidative stress protection via the transcriptional coactivator PGC-1α. Faseb. J. 20, 1889-1891.
71. Anderson, R. and Prolla, T. (2009) PGC-1α in aging and anti-aging interventions. Biochim. Biophys. Acta. 1790, 1059-1066.
72. Handschin, C. (2009) The biology of PGC-1α and its therapeutic potential. Trends Pharmacol. Sci. 30, 322-329.
73. Lin, J., Handschin, C., and Spiegelman, B. M. (2005) Metabolic control through the PGC-1 family of transcription coactivators. Cell. Metab. 1, 361-370.
74. Canto, C. and Auwerx, J. (2009) PGC-1a, SIRT1 and AMPK, an energy sensing network that controls energy expenditure. Curr. Opin. Lipidol. 20, 98-105.
75. Putman, C. T., Kiricsi, M., Pearcey, J., MacLean, I. M., Bamford, J. A., Murdoch, G. K., Dixon, W. T., and Pette, D. (2003) AMPK activation increases uncoupling protein-3 expression and mitochondrial enzyme activities in rat muscle without fibre type transitions. J. Physiol. 551, 169-178.
76. Zong, H., Ren, J. M., Young, L. H., Pypaert, M., Mu, J., Birnbaum, M. J., and Shulman, G. I. (2002) AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation. Proc. Natl. Acad. Sci.USA 99, 15983-15987.
77. Jager, S., Handschin, C., St-Pierre, J., and Spiegelman, B. M. (2007) AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1a. Proc. Natl. Acad. Sci. USA 104, 12017-12022.
78. Civitarese, A. E., Carling, S., Heilbronn, L. K., Hulver, M. H., Ukropcova, B., Deutsch, W. A., Smith, S. R., and Ravussin, E. (2007) Calorie restriction increases muscle mitochondrial biogenesis in healthy humans. PLoS Med. 4, e76.
79. Tan, L., Yu, J. T., and Guan, H. S. (2008) Resveratrol exerts pharmacological preconditioning by activating PGC-1α. Med. Hypotheses 71, 664-667.
80. Longo, V. D. and Kennedy, B. K. (2006) Sirtuins in aging and agerelated disease. Cell 126, 257-268.
81. Guarente, L. (2007) Sirtuins in aging and disease. Cold Spring Harb. Symp. Quant. Biol. 72, 483-488.
82. Guarente, L. (2008) Mitochondria - a nexus for aging, calorie restriction, and sirtuins? Cell 132, 171-176.
83. Kelly, T. J., Lerin, C., Haas, W., Gygi, S. P., and Puigserver, P. (2009) GCN5-mediated transcriptional control of the metabolic coac-tivator PGC-1β through lysine acetylation. J. Biol. Chem. 284, 19945-19952.
84. Powelka, A. M., Seth, A., Virbasius, J. V., Kiskinis, E., Nicoloro, S. M., Guilherme, A., Tang, X., Straubhaar, J., Cherniack, A. D., Parker, M. G., and Czech, M. P. (2006) Suppression of oxidative metabolism and mitochondrial biogenesis by the transcriptional corepressor RIP140 in mouse adipocytes. J. Clin. Invest. 116, 125-136.
85. Fan, M., Rhee, J., St-Pierre, J., Handschin, C., Puigserver, P., Lin, J., Jaeger, S., Erdjument-Bromage, H., Tempst, P., and Spiegelman, B. M. (2004) Suppression of mitochondrial respiration through recruitment of p160 myb binding protein to PGC-1a: modulation by p38 MAPK. Genes Dev. 18, 278-289.
86. Pan, D., Fujimoto, M., Lopes, A., and Wang, Y. X. (2009) Twist-1 is a PPARdelta-inducible, negative-feedback regulator of PGC-1α in brown fat metabolism. Cell 137, 73-86.
87. St-Pierre, J., Drori, S., Uldry, M., Silvaggi, J. M., Rhee, J., Jager, S., Handschin, C., Zheng, K., Lin, J., Yang, W., Simon, D. K., Bachoo, R., and Spiegelman, B. M. (2006) Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 127, 397-408.
88. Sandri, M., Lin, J., Handschin, C., Yang, W., Arany, Z. P., Lecker, S. H., Goldberg, A. L., and Spiegelman, B. M. (2006) PGC-1α protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription. Proc. Natl. Acad. Sci. USA 103, 16260-16265.
89. Adhihetty, P. J., Uguccioni, G., Leick, L., Hidalgo, J., Pilegaard, H., and Hood, D. A. (2009) The role of PGC-1{α} on mitochondrial function and apoptotic susceptibility in muscle. Am. J. Physiol. Cell Physiol. 297, C217-C225.
90. Handschin, C., Kobayashi, Y. M., Chin, S., Seale, P., Campbell, K. P., and Spiegelman, B. M. (2007) PGC-1α regulates the neuromuscular junction program and ameliorates Duchenne muscular dystrophy. Genes Dev. 21, 770-783.
91. Rustin, P., Bourgeron, T., Parfait, B., Chretien, D., Munnich, A., and Rotig, A. (1997) Inborn errors of the Krebs cycle: a group of unusual mitochondrial diseases in human. Biochim. Biophys. Acta. 1361, 185-197.
92. Lissens, W., De Meirleir, L., Seneca, S., Liebaers, I., Brown, G. K., Brown, R. M., Ito, M., Naito, E., Kuroda, Y., Kerr, D. S., Wexler, I. D., Patel, M. S., Robinson, B. H., and Seyda, A. (2000) Mutations in the X-linked pyruvate dehydrogenase (E1) α subunit gene (PDHA1) in patients with a pyruvate dehydrogenase complex deficiency. Hum. Mutat. 15, 209-219.
93. Kompare, M. and Rizzo, W. B. (2008) Mitochondrial fatty-acid oxidation disorders. Semin. Pediatr. Neurol. 15, 140-149.
94. Sewell, A. C., Bender, S. W., Wirth, S., Munterfering, H., Ijlist, L., and Wanders, R. J. (1994) Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: a severe fatty acid oxidation disorder. Eur. J. Pediatr. 153, 745-750.
95. Houstek, J., Kmoch, S., and Zeman, J. (2009) TMEM70 protein - a novel ancillary factor of mammalian ATP synthase. Biochim. Biophys. Acta. 1787, 529-532.
96. Zhu, Z., Yao, J., Johns, T., Fu, K., de Bie, I., Macmillan, C., Cuthbert, A. P., Newbold, R. F., Wang, J., Chevrette, M., Brown, G. K., Brown, R. M., and Shoubridge, E. A. (1998) SURF1, encoding a factor involved in the biogenesis of cytochrome c oxidase, is mutated in Leigh syndrome. Nat. Genet. 20, 337-343.
97. Teraoka, M., Yokoyama, Y., Ninomiya, S., Inoue, C., Yamashita, S., and Seino, Y. (1999) Two novel mutations of SURF1 in Leigh syndrome with cytochrome c oxidase deficiency. Hum. Genet. 105, 560-563.
98. Antonicka, H., Leary, S. C., Guercin, G. H., Agar, J. N., Horvath, R., Kennaway, N. G., Harding, C. O., Jaksch, M., and Shoubridge, E. A. (2003) Mutations in COX10 result in a defect in mitochondrial heme A biosynthesis and account for multiple, early-onset clinical phenotypes associated with isolated COX deficiency. Hum. Mol. Genet. 12, 2693-2702.
99. Lodi, R., Tonon, C., Calabrese, V., and Schapira, A. H. (2006) Friedreich's ataxia: from disease mechanisms to therapeutic interventions. Antioxid. Redox Signal. 8, 438-443.
100. Mansy, S. S. and Cowan, J. A. (2004) Iron-sulfur cluster biosynthesis: toward an understanding of cellular machinery and molecular mechanism. Acc. Chem. Res. 37, 719-725.
101. Lopez, L. C., Schuelke, M., Quinzii, C. M., Kanki, T., Rodenburg, R. J., Naini, A., Dimauro, S., and Hirano, M. (2006) Leigh syndrome with nephropathy and CoQ10 deficiency due to decaprenyl diphos-phate synthase subunit 2 (PDSS2) mutations. Am. J. Hum. Genet. 79, 1125-1129.
102. Mollet, J., Giurgea, I., Schlemmer, D., Dallner, G., Chretien, D., Delahodde, A., Bacq, D., de Lonlay, P., Munnich, A., and Rotig, A. (2007) Prenyldiphosphate synthase, subunit 1 (PDSS1) and OH-benzoate polyprenyltransferase (COQ2) mutations in ubiquinone deficiency and oxidative phosphorylation disorders. J. Clin. Invest. 117, 765-772.
103. Hauff, K. D. and Hatch, G. M. (2006) Cardiolipin metabolism and Barth Syndrome. Prog. Lipid Res. 45, 91-101.
104. Koshkin, V. and Greenberg, M. L. (2000) Oxidative phosphorylation in cardiolipin-lacking yeast mitochondria. Biochem. J. 347 (Part 3), 687-691.
105. McKenzie, M., Lazarou, M., Thorburn, D. R., and Ryan, M. T. (2006) Mitochondrial respiratory chain supercomplexes are destabilized in Barth Syndrome patients. J. Mol. Biol. 361, 462-469.
106. Wenz, T., Hielscher, R., Hellwig, P., Schagger, H., Richers, S., and Hunte, C. (2009) Role of phospholipids in respiratory cytochrome bc(1) complex catalysis and supercomplex formation. Biochim. Biophys. Acta. 1787, 609-616.
107. Longley, M. J., Graziewicz, M. A., Bienstock, R. J., and Copeland, W. C. (2005) Consequences of mutations in human DNA polymerase gamma. Gene 354, 125-131.
108. Copeland, W. C. (2008) Inherited mitochondrial diseases of DNA replication. Annu. Rev. Med. 59, 131-146.
109. Sharer, J. D. (2005) The adenine nucleotide translocase type 1 (ANT1): a new factor in mitochondrial disease. IUBMB Life 57, 607-614.
110. Emdadul Haque, M., Grasso, D., Miller, C., Spremulli, L. L., and Saada, A. (2008) The effect of mutated mitochondrial ribosomal proteins S16 and S22 on the assembly of the small and large ribosomal subunits in human mitochondria. Mitochondrion 8, 254-261.
111. Miller, C., Saada, A., Shaul, N., Shabtai, N., Ben-Shalom, E., Shaag, A., Hershkovitz, E., and Elpeleg, O. (2004) Defective mitochondrial translation caused by a ribosomal protein (MRPS16) mutation. Ann. Neurol. 56, 734-738.
112. O'Brien, T. W., O'Brien, B. J., and Norman, R. A. (2005) Nuclear MRP genes and mitochondrial disease. Gene 354, 147-151.
113. Valente, L., Tiranti, V., Marsano, R. M., Malfatti, E., Fernandez-Vizarra, E., Donnini, C., Mereghetti, P., De Gioia, L., Burlina, A., Castellan, C., Comi, G.P., Savasta, S., Ferrero, I., and Zeviani, M. (2007) Infantile encephalopathy and defective mitochondrial DNA translation in patients with mutations of mitochondrial elongation factors EFG1 and EFTu. Am. J. Hum. Genet. 80, 44-58.
114. Smeitink, J. A., Elpeleg, O., Antonicka, H., Diepstra, H., Saada, A., Smits, P., Sasarman, F., Vriend, G., Jacob-Hirsch, J., Shaag, A., Rechavi, G., Welling, B., Horst, J., Rodenburg, R. J., van den Heuvel, B., and Shoubridge, E. A. (2006) Distinct clinical phenotypes associated with a mutation in the mitochondrial translation elongation factor EFTs. Am. J. Hum. Genet. 79, 869-877.
115. Coenen, M. J., Antonicka, H., Ugalde, C., Sasarman, F., Rossi, R., Heister, J. G., Newbold, R. F., Trijbels, F. J., van den Heuvel, L. P., Shoubridge, E. A., and Smeitink, J. A. (2004) Mutant mitochondrial elongation factor G1 and combined oxidative phosphorylation deficiency. N. Engl. J. Med. 351, 2080-2086.
116. Bykhovskaya, Y., Casas, K., Mengesha, E., Inbal, A., and Fischel- Ghodsian, N. (2004) Missense mutation in pseudouridine synthase 1 (PUS1) causes mitochondrial myopathy and sideroblastic anemia (MLASA). Am. J. Hum. Genet. 74, 1303-1308.
117. Edvardson, S., Shaag, A., Kolesnikova, O., Gomori, J. M., Tarassov, I., Einbinder, T., Saada, A., and Elpeleg, O. (2007) Deleterious mutation in the mitochondrial arginyl-transfer RNA synthetase gene is associated with pontocerebellar hypoplasia. Am. J. Hum. Genet. 81, 857-862.
118. t Hart, L. M., Hansen, T., Rietveld, I., Dekker, J. M., Nijpels, G., Janssen, G. M., Arp, P. A., Uitterlinden, A. G., Jorgensen, T., Borch-Johnsen, K., Pols, H. A., Pedersen, O., van Duijn, C. M., Heine, R. J., and Maassen, J. A. (2005) Evidence that the mitochondrial leucyl tRNA synthetase (LARS2) gene represents a novel type 2 diabetes susceptibility gene. Diabetes 54, 1892-1895.
119. Bauer, M. F. and Neupert, W. (2001) Import of proteins into mitochondria: a novel pathomechanism for progressive neurodegeneration. J. Inherit. Metab. Dis. 24, 166-180.
120. Magen, D., Georgopoulos, C., Bross, P., Ang, D., Segev, Y., Goldsher, D., Nemirovski, A., Shahar, E., Ravid, S., Luder, A., Heno, B., Gershoni-Baruch, R., Skorecki, K., and Mandel, H. (2008) Mitochondrial hsp60 chaperonopathy causes an autosomal-recessive neurodegenerative disorder linked to brain hypomyelination and leukodystrophy. Am. J. Hum. Genet. 83, 30-42.
121. Hewamadduma, C. A., Kirby, J., Kershaw, C., Martindale, J., Dalton, A., McDermott, C. J., and Shaw, P. J. (2008) HSP60 is a rare cause of hereditary spastic paraparesis, but may act as a genetic modifier. Neurology 70, 1717-1718.
122. Frank, S. (2006) Dysregulation of mitochondrial fusion and fission: an emerging concept in neurodegeneration. Acta. Neuropathol. 111, 93-100.
123. Cartoni, R. and Martinou, J. C. (2009) Role of mitofusin 2 mutations in the physiopathology of Charcot-Marie-Tooth disease type 2A. Exp. Neurol. 218, 268-273.
124. Murdock, D. G., Boone, B. E., Esposito, L. A., and Wallace, D. C. (1999) Up-regulation of nuclear and mitochondrial genes in the skeletal muscle of mice lacking the heart/muscle isoform of the adenine nucleotide translocator. J. Biol. Chem. 274, 14429-14433.
125. Benton, C. R., Wright, D. C., and Bonen, A. (2008) PGC-1α-mediated regulation of gene expression and metabolism: implications for nutrition and exercise prescriptions. Appl. Physiol. Nutr. Metab. 33, 843-862.
126. Russell, A. P. (2005) PGC-1α and exercise: important partners in combating insulin resistance. Curr. Diabetes Rev. 1, 175-181.
127. Ojuka, E. O. (2004) Role of calcium and AMP kinase in the regulation of mitochondrial biogenesis and GLUT4 levels in muscle. Proc. Nutr. Soc. 63, 275-278.
128. Wu, H., Kanatous, S. B., Thurmond, F. A., Gallardo, T., Isotani, E., Bassel-Duby, R., and Williams, R. S. (2002) Regulation of mitochondrial biogenesis in skeletal muscle by CaMK. Science 296, 349-352.
129. Zeviani, M. (2008) Train, train, train! No pain, just gain. Brain 131, 2809-2811.
130. Taivassalo, T. and Haller, R. G. (2004) Implications of exercise training in mtDNA defects - use it or lose it? Biochim. Biophys. Acta. 1659, 221-231.
131. Taivassalo, T. and Haller, R. G. (2005) Exercise and training in mitochondrial myopathies. Med. Sci. Sports. Exerc. 37, 2094-2101.
132. Dong, W., Gao, D., and Zhang, X. (2007) Mitochondria biogenesis induced by resveratrol against brain ischemic stroke. Med. Hypotheses 69, 700-701.
133. Ruderman, N. B., Park, H., Kaushik, V. K., Dean, D., Constant, S., Prentki, M., and Saha, A. K. (2003) AMPK as a metabolic switch in rat muscle, liver and adipose tissue after exercise. Acta. Physiol. Scand. 178, 435-442.
134. Zhang, F., Lavan, B., and Gregoire, F. M. (2004) Peroxisome proliferator-activated receptors as attractive antiobesity targets. Drug News Perspect. 17, 661-669.
135. Bonnefont, J. P., Bastin, J., Behin, A., and Djouadi, F. (2009) Bezafibrate for an inborn mitochondrial β-oxidation defect. N. Engl. J. Med. 360, 838-840.
136. Yousuf, S., Atif, F., Ahmad, M., Hoda, N., Ishrat, T., Khan, B., and Islam, F. (2009) Resveratrol exerts its neuroprotective effect by modulating mitochondrial dysfunctions and associated cell death during cerebral ischemia. Brain Res. 1250, 242-253.
137. Kumar, A., Naidu, P. S., Seghal, N., and Padi, S. S. (2007) Neuroprotective effects of resveratrol against intracerebroventricular colchicine-induced cognitive impairment and oxidative stress in rats. Pharmacology 79, 17-26. (Pubitemid 46034173)
138. Francois, M., Richette, P., Tsagris, L., Fitting, C., Lemay, C., Benallaoua, M., Tahiri, K., and Corvol, M. T. (2006) Activation of the peroxisome proliferator-activated receptor α pathway potentiates interleukin-1 receptor antagonist production in cytokine-treated chondrocytes. Arthritis Rheum. 54, 1233-1245.
139. Xu, J., Racke, M. K., and Drew, P. D. (2007) Peroxisome proliferator-activated receptor-a agonist fenofibrate regulates IL-12 family cytokine expression in the CNS: relevance to multiple sclerosis. J. Neurochem. 103, 1801-1810.
140. Miura, S., Tomitsuka, E., Kamei, Y., Yamazaki, T., Kai, Y., Tamura, M., Kita, K., Nishino, I., and Ezaki, O. (2006) Overexpression of peroxisome proliferator-activated receptor gamma co-activator-1α leads to muscle atrophy with depletion of ATP. Am. J. Pathol. 169, 1129-1139.
141. Lehman, J. J., Barger, P. M., Kovacs, A., Saffitz, J. E., Medeiros, D. M., and Kelly, D. P. (2000) Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis. J. Clin. Invest. 106, 847-856.